Publicaciones en las que colabora con MANUEL LIZASOAÍN HERNÁNDEZ (27)

2023

  1. Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience

    Journal of Medical Virology, Vol. 95, Núm. 9

  2. Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 12, pp. 1485-1497

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  3. Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment

    Journal of Global Antimicrobial Resistance, Vol. 29, pp. 215-221

  4. Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa

    International Journal of Antimicrobial Agents, Vol. 59, Núm. 2

  5. Prognostic factors of OXA-48 carbapenemase-producing Klebsiella pneumoniae infection in a tertiary-care Spanish hospital: A retrospective single-center cohort study

    International Journal of Infectious Diseases, Vol. 119, pp. 59-68

  6. Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised Patients

    Antibiotics, Vol. 11, Núm. 11

2021

  1. Eradication of staphylococcus aureus post-sternotomy mediastinitis following the implementation of universal preoperative nasal decontamination with mupirocin: An interrupted time-series analysis

    Clinical Infectious Diseases, Vol. 73, Núm. 9, pp. 1685-1692

  2. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842

2020

  1. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain

    EClinicalMedicine, Vol. 23

2013

  1. A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

    Clinical Microbiology and Infection, Vol. 19, Núm. 1, pp. 56-61

  2. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation

    Clinical Microbiology and Infection, Vol. 19, Núm. 12, pp. 1132-1139

  3. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation

    Transplant Infectious Disease, Vol. 15, Núm. 4, pp. 405-415

2012

  1. Aspergillus tracheobronchitis: Report of 8 cases and review of the literature

    Medicine (United States), Vol. 91, Núm. 5, pp. 261-273

2011

  1. Acute graft pyelonephritis in renal transplant recipients: Incidence, risk factors and long-term outcome

    Nephrology Dialysis Transplantation, Vol. 26, Núm. 3, pp. 1065-1073

2010

  1. Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 12, pp. 5161-5166

2009

  1. Pretransplant lymphocyte count predicts the incidence of infection during the first two years after liver transplantation

    Liver Transplantation, Vol. 15, Núm. 10, pp. 1209-1216

  2. Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive aspergillosis in patients with febrile neutropenia

    Journal of Clinical Microbiology, Vol. 47, Núm. 2, pp. 379-384

2008

  1. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: An underdiagnosed etiology for obstructive uropathy and graft dysfunction - Results of a prospective cohort study

    Clinical Infectious Diseases, Vol. 46, Núm. 6, pp. 825-830